Standard Biotools (LAB) EBIT Growth (1y) (2011 - 2026)
Powered by 
Analysis
Standard Biotools (LAB) EBIT Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.64 Bn | 221.57 Bn | 8.34 Bn | 13.79% |
| 2 | Danaher | 144.47 Bn | 140.12 Bn | 3.61 Bn | 48.29% |
| 3 | Agilent Technologies | 40.90 Bn | 39.15 Bn | 1.04 Bn | 23.33% |
| 4 | Illumina | 30.90 Bn | 29.73 Bn | 770.00 Mn | 14.49% |
| 5 | Revvity | 13.85 Bn | 12.82 Bn | 416.87 Mn | -1.59% |
| 6 | Bio-Techne | 11.27 Bn | 11.00 Bn | 211.39 Mn | 411.30% |
| 7 | Bio-Rad Laboratories | 10.12 Bn | 8.50 Bn | 345.80 Mn | -5.84% |
| 8 | Repligen | 9.28 Bn | 8.27 Bn | 110.04 Mn | 0.58% |
| 9 | 10x Genomics | 8.70 Bn | 8.14 Bn | 112.50 Mn | -164.91% |
| 10 | Standard Biotools | 282.88 Mn | -193.84 Mn | 10.54 Mn | 1.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20% |
| Mar 31, 2026 | 53.67% |
| Dec 31, 2025 | 5.51% |
| Sep 30, 2025 | -23.37% |
| Jun 30, 2025 | 15.08% |
| Mar 31, 2025 | 55.19% |
| Dec 31, 2024 | -21.96% |
| Sep 30, 2024 | -26.11% |
| Jun 30, 2024 | -73.43% |
| Mar 31, 2024 | -262.70% |
| Dec 31, 2023 | -1.30% |
| Sep 30, 2023 | 27.06% |
| Jun 30, 2023 | 54.75% |
| Mar 31, 2023 | 39.67% |
| Sep 30, 2022 | 48.35% |
| Jun 30, 2022 | -5.40% |
| Mar 31, 2022 | -42.36% |
| Sep 30, 2021 | -928.55% |
| Jun 30, 2021 | -166.56% |
| Mar 31, 2021 | -29.30% |